NCT05259020: To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers |
|
|
| Recruiting | 1 | 60 | RoW | ID140009, ID1803+ID1805 | IlDong Pharmaceutical Co Ltd | Dyslipidemias, Hypertension | 03/22 | 03/22 | | |
NCT05525650: Comparative Evaluation of Safety and Immune Activity of New Immunotherapeutic Agents for HDM Allergic Rhinitis Patients |
|
|
| Enrolling by invitation | 1 | 54 | RoW | House Dust Mite Extract, Dermatophagoides Farinae | RAPHAS | Mite Allergy, Rhinitis, Allergic, House Dust Mite Rhinitis | 12/24 | 06/25 | | |